GPCR Modulation in Breast Cancer

Breast cancer is the most prevalent cancer found in women living in developed countries. Endocrine therapy is the mainstay of treatment for hormone-responsive breast tumors (about 70% of all breast cancers) and implies the use of selective estrogen receptor modulators and aromatase inhibitors. In co...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 19; no. 12; p. 3840
Main Authors Lappano, Rosamaria, Jacquot, Yves, Maggiolini, Marcello
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 02.12.2018
MDPI
Subjects
Online AccessGet full text

Cover

Loading…